Bill > SB155

This bill, the Anti-Drug Diversion Act, modifies the requirements for prescribing certain types of opioid drugs in Oklahoma. The key provisions are: 1. It limits initial opioid prescriptions for acute pain to a 7-day supply for adults and minors, with specific requirements for practitioners to assess patients, access prescription monitoring data, and discuss the risks of opioid use. 2. It requires practitioners to conduct urine drug tests, periodically review treatment progress, and attempt to reduce opioid dosages for patients on chronic opioid therapy. 3. It exempts certain patient populations, like those with cancer or receiving end-of-life care, from these new requirements. 4. It requires health insurance plans to have proportional cost-sharing for initial opioid prescriptions or equivalent to a 30-day supply. 5. It mandates that providers adopting written policies for informed consent with patients on long-term opioid therapy. The bill is set to take effect on November 1, 2019.

Health and Social Services

http://www.oklegislature.gov/BillInfo.aspx?Bill=sb155&Session=1900